Leidos - LDOS Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Hold
Consensus Price Target: $113.43
Forecasted Upside: 24.13%
Number of Analysts: 6
Breakdown:
0 Sell Ratings
4 Hold Ratings
2 Buy Ratings
0 Strong Buy Ratings

^$91.38 As of 03/24/2023 01:00 AM ET

▲ +1.1 (1.22%)

1 month | 3 months | 12 months

Get New Leidos Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for LDOS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LDOS

^$113.43

▲ +24.13% Upside Potential

This price target is based on 6 analysts offering 12 month price targets for Leidos in the last 3 months. The average price target is $113.43, with a high forecast of $132.00 and a low forecast of $103.00. The average price target represents a 24.13% upside from the last price of $91.38.

Current Consensus is Hold

The current consensus among 6 polled investment analysts is to hold stock in Leidos. This rating changed within the last month from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
5 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

10/2/2021

0 strong buy ratings
6 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

12/31/2021

0 strong buy ratings
6 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

3/31/2022

0 strong buy ratings
5 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

6/29/2022

0 strong buy ratings
4 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

9/27/2022

0 strong buy ratings
4 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

12/26/2022

0 strong buy ratings
4 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

2/24/2023

0 strong buy ratings
2 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

3/26/2023

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
2/16/2023	Citigroup	Lower Target	Buy	$130.00 ➝ $124.00	Low
2/15/2023	Morgan Stanley	Lower Target	Equal Weight	$111.00 ➝ $105.00	Low
2/15/2023	Royal Bank of Canada	Lower Target	Sector Perform	$112.00 ➝ $105.00	Low
2/15/2023	Wells Fargo & Company	Lower Target	Equal Weight	$114.00 ➝ $103.00	Low
1/3/2023	Morgan Stanley	Lower Target	Equal Weight	$112.00 ➝ $111.00	Low
12/14/2022	Morgan Stanley	Boost Target	Equal Weight	$110.00 ➝ $112.00	Low
12/8/2022	Citigroup	Initiated Coverage	Buy	$130.00	Low
12/2/2022	Royal Bank of Canada	Boost Target		$105.00 ➝ $112.00	Low
11/8/2022	Wells Fargo & Company	Boost Target		$105.00 ➝ $114.00	Low
11/2/2022	Royal Bank of Canada	Boost Target	Sector Perform	$100.00 ➝ $105.00	Low
8/29/2022	Royal Bank of Canada	Initiated Coverage	Sector Perform	$106.00	Low
8/3/2022	Morgan Stanley	Boost Target	Equal Weight	$107.00 ➝ $110.00	Low
8/3/2022	Wells Fargo & Company	Lower Target	Equal Weight	$109.00 ➝ $105.00	Low
6/7/2022	Barclays	Downgrade	Overweight ➝ Equal Weight	$105.00	High
5/4/2022	Truist Financial	Boost Target		$108.00 ➝ $120.00	Low
4/14/2022	The Goldman Sachs Group	Boost Target	Buy	$118.00 ➝ $132.00	Low
3/24/2022	Wells Fargo & Company	Downgrade	Overweight ➝ Equal Weight	$97.00 ➝ $113.00	High
3/18/2022	Morgan Stanley	Lower Target	Equal Weight	$109.00 ➝ $107.00	High
3/17/2022	Stifel Nicolaus	Initiated Coverage	Buy		High
3/1/2022	William Blair	Reiterated Rating	Outperform		Medium
3/1/2022	The Goldman Sachs Group	Boost Target	Buy	$103.00 ➝ $118.00	High
2/17/2022	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy		High
2/16/2022	Robert W. Baird	Lower Target		$110.00 ➝ $100.00	High
2/16/2022	Wells Fargo & Company	Lower Target		$104.00 ➝ $97.00	High
1/24/2022	Barclays	Lower Target	Overweight	$115.00 ➝ $110.00	Low
11/3/2021	Wells Fargo & Company	Lower Target	Overweight	$116.00 ➝ $113.00	High
10/8/2021	Cowen	Reiterated Rating	Buy	$119.00	Medium
8/20/2021	Argus	Downgrade	Buy ➝ Hold		Low
8/4/2021	Robert W. Baird	Lower Target	Outperform	$120.00 ➝ $110.00	Medium
6/11/2021	Morgan Stanley	Boost Target	Equal Weight	$105.00 ➝ $109.00	Medium
6/8/2021	The Goldman Sachs Group	Upgrade	Buy ➝ Conviction-Buy		High
6/2/2021	Argus	Boost Target	Buy	$100.00 ➝ $118.00	Low
5/20/2021	Citigroup	Initiated Coverage	Buy		Low
5/12/2021	Wells Fargo & Company	Initiated Coverage	Overweight	$120.00	Low
4/5/2021	The Goldman Sachs Group	Upgrade	Neutral ➝ Buy	$111.00 ➝ $116.00	Medium
3/10/2021	Morgan Stanley	Lower Target	Equal Weight	$113.00 ➝ $105.00	Low
3/8/2021	Argus	Lower Target	Buy	$110.00 ➝ $100.00	Low
3/3/2021	Bank of America	Boost Target	Buy	$120.00 ➝ $125.00	Low
2/24/2021	Credit Suisse Group	Lower Target	Outperform	$137.00 ➝ $118.00	High
11/3/2020	Credit Suisse Group	Boost Target	Outperform	$120.00 ➝ $131.00	High
9/23/2020	Barclays	Upgrade	Equal Weight ➝ Overweight	$109.00 ➝ $110.00	High
9/22/2020	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$115.00	High
8/21/2020	Evercore ISI	Initiated Coverage	Outperform		High
6/10/2020	Robert W. Baird	Initiated Coverage	Outperform	$140.00	High
5/11/2020	Jefferies Financial Group	Lower Target	Buy	$140.00 ➝ $120.00	Low
5/7/2020	Credit Suisse Group	Initiated Coverage	Outperform	$133.00	Low
5/6/2020	JPMorgan Chase & Co.	Boost Target	Neutral	$99.00 ➝ $113.00	Low
5/4/2020	Wells Fargo & Company	Boost Target	Overweight	$105.00 ➝ $114.00	High
4/20/2020	Citigroup	Upgrade	Neutral ➝ Buy	$115.00	Medium
4/14/2020	SunTrust Banks	Lower Target	Buy	$135.00 ➝ $110.00	High
4/14/2020	Morgan Stanley	Boost Target	Equal Weight	$95.00 ➝ $103.00	Medium
4/2/2020	Wells Fargo & Company	Lower Target	Overweight	$120.00 ➝ $105.00	Medium
3/30/2020	William Blair	Initiated Coverage	Outperform		High
3/24/2020	Morgan Stanley	Lower Target	Equal Weight	$98.00 ➝ $95.00	High
3/20/2020	Bank of America	Initiated Coverage	Buy	$105.00	Medium
3/3/2020	Wells Fargo & Company	Upgrade	Equal Weight ➝ Overweight	$120.00	Low
3/2/2020	Stifel Nicolaus	Upgrade	Hold ➝ Buy	$130.00	High
2/26/2020	JPMorgan Chase & Co.	Boost Target	Neutral	$105.00 ➝ $116.00	Medium
2/20/2020	Stifel Nicolaus	Boost Target	Hold	$90.00 ➝ $130.00	Low
2/19/2020	SunTrust Banks	Boost Target	Buy	$117.00 ➝ $135.00	High
2/19/2020	Cfra	Downgrade	Buy ➝ Hold		High
2/13/2020	Cowen	Reiterated Rating	Buy	$111.00	Medium
2/6/2020	Wells Fargo & Company	Boost Target	Equal Weight	$102.00 ➝ $110.00	High
2/5/2020	SunTrust Banks	Reiterated Rating	Buy ➝ Positive	$117.00	Medium
1/9/2020	Wells Fargo & Company	Downgrade	Overweight ➝ Equal Weight	$102.00	High
12/23/2019	Morgan Stanley	Boost Target	Equal Weight ➝ Equal Weight	$90.00 ➝ $98.00	Low
12/18/2019	SunTrust Banks	Boost Target	Buy	$95.00 ➝ $105.00	High
12/18/2019	Wells Fargo & Company	Boost Target	Buy ➝ Overweight	$95.00 ➝ $102.00	High
12/18/2019	Credit Suisse Group	Boost Target	Outperform	$97.00 ➝ $111.00	High
12/11/2019	Credit Suisse Group	Reiterated Rating	Buy	$97.00	Low
10/29/2019	Cowen	Reiterated Rating	Buy	$89.00	High
10/10/2019	Morgan Stanley	Boost Target	Equal Weight	$81.00 ➝ $83.00	Low
9/24/2019	JPMorgan Chase & Co.	Initiated Coverage	Neutral	$95.00	Low
9/20/2019	Barclays	Initiated Coverage	Equal Weight	$97.00	High
8/21/2019	Morgan Stanley	Boost Target	Equal Weight	$75.00 ➝ $81.00	Low
7/31/2019	SunTrust Banks	Boost Target	Buy	$95.00	Low
7/9/2019	Citigroup	Downgrade	Buy ➝ Neutral	$75.00 ➝ $83.00	Low
6/3/2019	Morgan Stanley	Initiated Coverage	Equal Weight ➝ Equal Weight	$75.00	Low
5/16/2019	Argus	Boost Target	Buy ➝ Positive	$82.00	Medium
5/15/2019	Credit Suisse Group	Boost Target	Outperform	$82.00 ➝ $88.00	Low
5/15/2019	Wells Fargo & Company	Boost Target	Outperform ➝ Positive	$80.00 ➝ $85.00	Low
5/9/2019	The Goldman Sachs Group	Reiterated Rating	Neutral	$75.00	Low
4/30/2019	Cowen	Reiterated Rating	Buy	$77.00	Low
2/22/2019	Drexel Hamilton	Reiterated Rating	Buy	$75.00	Low
2/19/2019	Cowen	Reiterated Rating	Buy	$70.00	High
10/29/2018	Argus	Lower Target	Buy ➝ Buy	$80.00 ➝ $70.00	High
10/17/2018	Cowen	Reiterated Rating	Buy	$77.00	Low
6/18/2018	The Goldman Sachs Group	Downgrade	Buy ➝ Neutral		Medium
5/8/2018	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy	$82.00	Medium

(Data available from 3/26/2018 forward)

News Sentiment Rating

0.67 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

9 very positive mentions
36 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

8/28/2022

3 very positive mentions
20 positive mentions
1 negative mentions
1 very negative mentions

Mentions as of

9/27/2022

3 very positive mentions
5 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

10/27/2022

9 very positive mentions
28 positive mentions
0 negative mentions
1 very negative mentions

Mentions as of

11/26/2022

12 very positive mentions
6 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

12/26/2022

13 very positive mentions
8 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

1/25/2023

17 very positive mentions
27 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

2/24/2023

18 very positive mentions
22 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

3/26/2023

Current Sentiment

Recent Stories by Sentiment

Very Negative

No very negative mentions tracked during this time.

Leidos Holdings, Inc. engages in the provision of services and solutions in the defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment provides services, solutions, and products focusing on digital modernization, mission systems and integration, Command, Control, Computers, Communications, Intelligence, Surveillance and Reconnaissance (""C4ISR"") technologies and services, maritime solutions, transformative software, analytics, intelligence analysis, mission support and logistics services, weapons systems and space systems and solutions. The Civil segment focuses on modernizing infrastructure, systems, and security. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.

Today's Range

Now: $91.38

$89.67

$91.43

50 Day Range

MA: $96.49

$90.28

$101.24

52 Week Range

Now: $91.38

$87.24

$111.12

Volume

953,783 shs

Average Volume

919,478 shs

Market Capitalization

$12.52 billion

P/E Ratio

18.50

Dividend Yield

1.60%

Beta

0.76

Frequently Asked Questions

What sell-side analysts currently cover shares of Leidos?: The following equities research analysts have issued research reports on Leidos in the last twelve months: Barclays PLC, Citigroup Inc., Morgan Stanley, Royal Bank of Canada, StockNews.com, The Goldman Sachs Group, Inc., Truist Financial Co., and Wells Fargo & Company.
View the latest analyst ratings for LDOS.
What is the current price target for Leidos?: 7 Wall Street analysts have set twelve-month price targets for Leidos in the last year. Their average twelve-month price target is $113.43, suggesting a possible upside of 24.1%. The Goldman Sachs Group, Inc. has the highest price target set, predicting LDOS will reach $132.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $103.00 for Leidos in the next year.
View the latest price targets for LDOS.
What is the current consensus analyst rating for Leidos?: Leidos currently has 4 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in LDOS, but not buy more shares or sell existing shares.
View the latest ratings for LDOS.
What other companies compete with Leidos?: Other companies that are similar to Leidos include Textron, Huntington Ingalls Industries, Elbit Systems, CAE and Curtiss-Wright. Learn More about companies similar to Leidos.
How do I contact Leidos' investor relations team?: Leidos' physical mailing address is 1750 PRESIDENTS STREET, RESTON VA, 20190. The aerospace company's listed phone number is (571) 526-6000 and its investor relations email address is [email protected] The official website for Leidos is www.leidos.com. Learn More about contacing Leidos investor relations.

Leidos - LDOS Stock Price Target and Predictions

Analyst Price Target for LDOS

Current Consensus is Hold

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.67 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Leidos?

What is the current price target for Leidos?

What is the current consensus analyst rating for Leidos?

What other companies compete with Leidos?

How do I contact Leidos' investor relations team?